CS Paper Radar

Orchestra: Corroboration-Based Regulatory Candidate Discovery via Composed Bioinformatics MCP Agents

Jose A. Bird

cs.MA q-bio.MN ·submitted 2026-08-27 19:23 UTC · v4

Abstract

Orchestra composes two independently built bioinformatics MCP servers -- RegNetAgents, which infers regulatory network topology, and CASCADE, which provides independent functional evidence (LINCS knockdown, DepMap essentiality, super-enhancer status, DoRothEA transcription-factor confidence) -- into one multi-agent LangGraph workflow. Its central claim is that requiring the two systems to agree on a candidate regulator yields a more trustworthy candidate than either alone. We test this on the TCGA tumor-acquired regulator tier, selecting each query's ten regulators by ARACNe mutual-information edge weight. Across BRCA/COAD focal genes and matched negative controls, requiring at least 2 of 4 evidence sources predicts known-driver status (IntOGen) among focal genes (odds ratio 3.15, Benjamini-Hochberg-adjusted p=0.016; 2.92 after deduplication) but shows no association among negative controls (p=0.70); a single source does not in BRCA/COAD. In a second panel (STAD) the pattern reproduces and is stronger (OR 6.71, adjusted p=0.0047), again with no association in controls. Corroboration adds value beyond MI edge weight in both panels (BRCA/COAD p=0.039; STAD p=0.0001), though modestly in BRCA/COAD. Deduplication, a permutation test and a reproduction of RegNetAgents' published results agree; a second, separately derived driver list (Vogelstein et al. 2013) is directionally consistent but too sparse to reach significance. All experiments invoke Orchestra's real agentic entry point.

Comment
20 pages, 3 figures. v4: driver reference set changed from OncoKB to IntOGen; data re-collected on RegNetAgents v1.3.0 / CASCADE v1.5.0 with updated panels; all results, tables and figures updated

Closest papers

Nearest neighbours by meaning across the whole index.

Unlocking the Regulatory Genome by ARGUS: An Evidence-Constrained Agentic Framework for Interpreting Single Nucleotide Variants

cs.AI q-bio.GNcs.LG ·2026-10-08 ·Pratik Dutta, Matthew B. Obusan, Max Chao, Rekha Sathian, Nimisha Papineni +1 more
publishedcode/data similarity 0.62
Abstract · Accepted at the NeurIPS 2026 Workshop on Agentic AI for Biological Discovery (AgenticLS). Code: https://github.com/duttaprat/ARGUS

Over 90% of disease-associated variants from genome-wide association studies fall in noncoding regulatory regions, yet their functional interpretation remains a central open problem in genomic medicine. Large language models prompted to interpret such variants routinely hallucinate transcription factor (TF) binding changes, fabricate experimental support, and assign biological significance to statistically negligible signals. We present ARGUS (Agentic Regulatory Genomics for an Uncertainty-aware Scientist), which strictly separates deterministic biological computation from LLM-mediated reasoning. ARGUS wraps 458 DNABERT-based TF binding models in a hypothesis-directed investigation loop where a planner selects evidence sources based on current uncertainty, a verifier deterministically interprets each observation, and intermediate results change the investigation path. On variant rs6983267 at the 8q24 cancer risk locus, the same planner produces four divergent trajectories for four TFs. FOXA1 is rescued in 3 steps when real ADASTRA allele-specific binding data (15 experiments, FDR = 0.030) reveals a model false negative masked by saturation. KLF6 traverses 8 steps across ADASTRA, JASPAR motif analysis, and ENCODE cCRE regulatory annotation before abstaining due to mixed indirect evidence. RAD21 abstains in 8 steps after ADASTRA returns a coverage-qualified but nonsignificant allelic test (5 experiments, FDR = 0.65), and SP1, which shares FOXA1's saturated retained prediction, abstains because no direct experimental evidence exists at this locus. All observations come from real ADASTRA, JASPAR, and ENCODE cCRE queries; none are simulated. A comparison of fixed-priority and LLM-mediated planning shows that the LLM planner reaches identical verdicts with fewer tool calls by declining evidence that cannot resolve the claim under test.

0.45

Attribution-based diagnostics for single-cell foundation models

cs.LG q-bio.QM ·2026-11-02 ·Farnoush Rezaei Jafari, Tristan Lazard, Kenza Bouzid, Shruthi Bannur, Jeremiah Wander +4 more
hot direction similarity 0.58
Abstract

Single-cell RNA foundation models (scFMs) are increasingly used for in-silico biological discovery, yet predictive performance alone does not reveal whether their decisions rely on biologically meaningful signals or model-specific shortcuts. We systematically investigate post-hoc attribution of downstream predictions across two tasks: cell-type annotation using pretrained Cell2Sentence and scGPT models, and perturbation prediction using scGPT+STATE in a controlled setting. For cell annotation, we use attribution to assess whether predictions rely on established marker genes and how their relevance varies with model architecture, expression rank, and the surrounding cellular context. For perturbation prediction, we compare attribution patterns with known regulatory ground-truth in a synthetic setting to assess what they reveal about the model's learned computations. Across these tasks, attribution reveals biological feature use, contextual interactions, contributions from different input pathways, learning progression, associations with prediction quality, and potential pitfalls that are not fully captured by standard performance metrics. Experiments with complete and limited regulatory knowledge further demonstrate that conclusions drawn from attribution depend strongly on the choice of biological reference, baseline, and null model. Together, these findings highlight the value of attribution as a flexible post-hoc diagnostic for understanding model behavior, identifying potential issues, and informing the development of scFMs.

0.24

Diversity Preservation Recovers Transcription Factor Motifs Across Challenging Confounder Landscapes

cs.NE q-bio.GN ·2026-11-16 ·Alejandro Medina, Mary Lauren Benton
similarity 0.57
Abstract

Motif discovery is a process where DNA sequences are searched for the short patterns, called motifs, that transcription factor (TF) proteins bind. However, the motif lengths are often unknown and motif attribution often competes with a near-identical motif of a related protein. In this work, we pair a motif genotype whose length emerges from an evolvable gate with MAP-Elites archives organized by three descriptor pairs, and validate every motif against the full HOCOMOCO database. On five liver ChIP-seq datasets spanning distinct confounder landscapes, a $(μ + λ)$ baseline differing only in survivor selection collapses onto a single motif and never ranks the target first across three datasets, while every MAP-Elites archive does so in at least 13 of 30 seeds on every dataset. Against the motif discovery tool MEME, run on the same sequences and validated identically, the archives recover the target signal as reliably on four datasets and more robustly when motif width is constrained. Neither method ranks the target above its closest relatives on HNF4A and JUND over the full width range, but narrow archive motifs rank HNF4A first in up to 43% of seeds, where MEME misses the motif in all settings. Diversity preservation improves our ability to recover consistent motif signal, although motif annotation remains a challenging problem for all methods we tested.

0.26

Do Perturbation Predictors Learn Gene Interactions? Diagnosing Extrapolation in Agentic Screening

cs.LG cs.AIq-bio.GN ·2026-10-01 ·Ziyuan Gao
publishedcode/data similarity 0.56
Abstract · Accepted at the NeurIPS 2026 Workshop ML4Molecules: Agentic Systems for Molecular Sciences

High-throughput perturbation screens increasingly use machine-learning models to predict the effects of gene combinations that were never measured. A difficult case arises when both genes in a test pair were seen individually during training, but their combination was not. In this setting, standard OOD methods often fail because neither gene appears unfamiliar on its own. We therefore compare each model prediction with a simple additive prediction obtained by summing the two observed single-gene effects. The difference between them, which we call additive disagreement (AD), measures how much extra interaction effect the model introduces for an unseen combination. Across eight prediction methods and three Perturb-seq datasets, specialised neural predictors do not consistently outperform this simple additive baseline. More importantly, predictions with larger deviations from the additive baseline tend to have larger errors. Conventional output-based and embedding-based confidence signals are inconsistent across datasets and models, whereas AD remains informative across all evaluated compositional settings. We further study how this signal can guide decisions in an agentic perturbation-screening workflow. The code is available at https://github.com/zygao930/OOD.

0.44

Bridging Graph and Pairwise Learning for Gene Regulatory Network Inference from scRNA-seq Data

cs.AI q-bio.GN ·2026-11-10 ·Hang Li, Jiaxin Qi, Yan Cui, Yuhua Zheng, Jianqiang Huang
publishedbenchmarkcode/data similarity 0.56
Abstract · Accepted to Bioinformatics

Motivation: Gene regulatory networks (GRNs) capture the underlying interactions through which transcription factors (TFs) regulate genes. Based on gene expression data, existing GRN inference approaches generally fall into two categories: graph-based methods, which model the GRN as a whole graph, and pairwise-based methods, which decompose the GRN into individual TF-target gene pairs for modeling. However, each approach exhibits limitations that are precisely the strengths of its counterpart. Graph-based methods tend to overfit due to their reliance on a single training graph, whereas pairwise-based methods benefit from abundant TF-target training pairs. In contrast, pairwise-based methods overlook the global topological structure, which is essential for comprehensively capturing regulatory mechanisms. Results: To address these limitations, we propose scGPL, an end-to-end unified framework that jointly models global regulatory topology and local interactions. scGPL extracts macro-level features from the global regulatory graph and introduces a dynamic, importance-guided subgraph sampling mechanism to capture fine-grained local dependencies. By fusing global representations with subgraph-enhanced local features, our framework bridges the gap between the two paradigms, incorporating essential whole-graph topological dependencies while retaining the data abundance advantage of pairwise methods. Extensive experiments on seven benchmark datasets demonstrate that scGPL consistently achieves state-of-the-art performance, with up to 13.7% improvement over the strongest baseline, validating the effectiveness of our integrative design. Availability and implementation: The source code is maintained on GitHub (https://github.com/talent-hang/scGPL), and the datasets and versioned releases are archived at https://doi.org/10.5281/zenodo.21608485 for reproducibility.

0.39

Agentic AI uncovers conserved cross-tissue protein co-abundance programs inaccessible to single-dataset analysis

cs.AI q-bio.MN ·2026-08-29 ·Dehao Wu, Runyu Guan, Qiqi Xie, Yang Li, Haohan Wang
code/data similarity 0.55
Abstract · 12 pages, 6 figures

Protein co-abundance clusters preserved across tissues can nominate shared disease mechanisms and therapeutic targets, particularly where proteins implicated in organ-confined diseases converge in other tissues. Yet cross-tissue proteomic studies have examined pre-selected tissue pairs, leaving most combinations, and non-obvious relationships among them, unexplored. Exhaustive comparison requires consistently assessing thousands of candidate clusters from hundreds of tissue-pair networks across heterogeneous evidence, a scale beyond manual curation. We present an LLM-agent framework for large-scale, evidence-grounded comparison of tissue-specific protein co-abundance networks. From sample-level proteomic data, it constructs tissue networks, derives conserved clusters for each tissue pair, integrates evidence from expression atlases, interaction and complex databases, pathways, disease associations and the literature, and proposes mechanistic hypotheses in which every conclusion cites its evidence. Applied to all 231 pairs among 22 human tissues and sample groups, it identified 1,825 conserved clusters in 216 tissue pairs. Co-abundance relationships were shared beyond chance in 76% of pairs, including unrelated organs, and shared clusters were only weakly associated with abundance similarity. Clusters were enriched 3.7- to 6.9-fold for known interactions and complex memberships, and 379 of 793 testable clusters replicated in independent CPTAC proteomes. Some clusters pointed to relationships absent from current databases: one shared by liver and bone marrow linked three genes causing inherited white matter disorders, suggesting a common mechanism via the integrated stress response. Conserved co-abundance clusters thus offer a hypothesis-generating resource for studying disease proteins beyond the affected organ. Code: https://github.com/jacob20030316-crypto/Protein_Co_Abundance_Agent

0.54

CellCanon: An Agentic Cellular World Model for Prediction, Explanation, and Observation-Driven Updating

cs.AI q-bio.QM ·2026-11-04 ·Zhaokang Liang, Shuyang Zhuang, Xiaoran Jiao, Hao Chen
benchmarkcode/datahot direction similarity 0.54
Abstract · 31 pages, 5 figures. Code: https://github.com/ZhaokangLiang123/CellCanon

Biological discovery requires using molecular knowledge and new measurements to infer responses beyond the conditions already observed. We introduce CellCanon, the first agentic cellular world model to unify single-cell expression prediction, evidence-grounded explanation, and observation-driven updating. Its predictive core reuses condition-level biological evidence across gene-specific numerical readouts to guide single-cell expression generation. A shared world state links predictions, acquired measurements, and source-linked claims, supporting explanation and revision. On 339 held-out SciPlex3 conditions across three cell lines, CellCanon improves differential-expression AUPRC and Macro-F1 over the best baseline for each metric by 63.3% and 17.3%, respectively, and direction Macro-F1 by 7.2%. Relative to gene-wise reasoning on matched drug-cell cohorts, measured language-model token use falls by 99.77% for Predict and 98.41% for Explain. On the source-grounded benchmark, Explain correctly answers all answerable questions with supporting proofs and identifies all insufficient-evidence cases. In simulated experimental feedback, Update uses one measured source context per drug to exceed the best fine-tuned baselines in differential-expression AUPRC and Macro-F1 without changing model weights. Together, these capabilities support a cumulative account of cellular responses, with predictions and biological judgments that can be revised as evidence accumulates.

0.36

Ensemble Classification and Cancer-Specific Gene Signatures from Quality-Aware Hybrid Gene Selection in TCGA RNA-Seq data

cs.LG ·2026-10-31 ·Tareque Mohmud Chowdhury, Abu Raihan Mostofa Kamal
similarity 0.54
Abstract · 17 pages, 6 figures, 3 tables and 1 supplementary file

Gene-expression classifiers of cancer type are usually developed and validated within one cohort using random splits. Starting from a quality-aware hybrid Boruta selector from earlier work, we developed and evaluated ensemble classifiers and cancer-specific gene signatures. Using 10,469 TCGA tumours of 33 types, we compared five learners and three ensembles under decision rules fixed in advance, reran the selection in site-grouped cross-validation, transferred a breast-cancer subtype panel to 3273 tumours of the independent SCAN-B cohort, and built five-gene stage~I tumour versus adjacent-normal panels for nine cancer types. Logistic regression (LR) was the most accurate and best-calibrated single learner (balanced accuracy 0.943 on the locked test set). Stacking added at most 0.006 with 1000 genes but improved on LR in every fold with a minimal 100-gene panel; a hierarchical model did not reduce within-group confusion. Site-grouped validation lowered balanced accuracy by 0.027, almost entirely in colon and rectal cancer (0.008 without them and the untestable LAML). On SCAN-B, the subtype panel reached 0.855, close to the 50 PAM50 genes (0.876). Stage~I panels reached ROC AUC >= 0.99 in held-out patients and detected most later-stage tumours. Ensembles help most with a minimal panel; with 1000 genes, a calibrated linear model suffices.

0.26